Rebekka Duhen

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.

Rebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye

Pageof 1

Frequent Collaborators

1 joint publications

Alexandra K Frye

1 joint publications

Eric Tran

1 joint publications

Venkatesh Rajamanickam

1 joint publications

Rom S Leidner